Unity Biotechnology (NASDAQ:UBX – Get Rating) had its price target upped by Citigroup from $5.00 to $6.00 in a report published on Friday, The Fly reports. Several other equities analysts also recently commented on the company. Wedbush decreased their target price on Unity Biotechnology from $35.00 to $5.00 and set an outperform rating on the […]
Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 952,200 shares, a drop of 17.2% from the April 30th total of 1,150,000 shares. Based on an average daily trading volume, of 417,800 shares, the days-to-cover ratio […]
Unity Biotechnology (NASDAQ:UBX – Get Rating) had its price objective boosted by Citigroup from $5.00 to $6.00 in a research report sent to investors on Friday morning, The Fly reports. Several other research firms also recently commented on UBX. Mizuho dropped their price objective on shares of Unity Biotechnology from $12.00 to $6.00 and set […]
Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) – Equities researchers at Wedbush increased their Q2 2023 earnings per share (EPS) estimates for shares of Unity Biotechnology in a note issued to investors on Monday, May 15th. Wedbush analyst A. Argyrides now anticipates that the company will earn ($0.70) per share for the quarter, up from […]
Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) – Equities research analysts at Wedbush cut their FY2026 earnings per share (EPS) estimates for Unity Biotechnology in a research report issued to clients and investors on Tuesday, April 25th. Wedbush analyst A. Argyrides now forecasts that the company will earn ($13.02) per share for the year, down […]